Skip to main navigation Skip to search Skip to main content

Staphylococci

  • Queen Elizabeth Hospital Birmingham

Research output: Contribution to journalArticlepeer-review

103   Link opens in a new tab Citations (SciVal)

Abstract

Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to β-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci. © 2007 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)S23-S32
JournalInternational Journal of Antimicrobial Agents
Volume29
Issue numberSuppl. 3
DOIs
Publication statusPublished - May 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • antibiotics
  • antimicrobial resistance
  • coagulase-negative staphylococci
  • staphylococcus aureus

Fingerprint

Dive into the research topics of 'Staphylococci'. Together they form a unique fingerprint.

Cite this